Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant
2008

Study of Mycobacterium bovis BCG Russia Vaccine Strain

Sample size: 16 publication 10 minutes Evidence: moderate

Author Information

Author(s): Keller Peter M, Böttger Erik C, Sander Peter

Primary Institution: Institut für Medizinische Mikrobiologie, Universität Zürich

Hypothesis

We aimed to inactivate recA by allelic replacement in BCG vaccine strains representing different phylogenetic lineages.

Conclusion

BCG Russia is an ancient vaccine strain with a natural recA mutation that contributes to its genomic stability.

Supporting Evidence

  • BCG Russia was found to have a single nucleotide insertion in the recA gene.
  • The recA mutation leads to a frameshift and a premature stop codon.
  • BCG Russia showed a high degree of genomic stability compared to other substrains.

Takeaway

The study looked at a tuberculosis vaccine strain and found that a small change in its genes helps it stay stable and not change too much over time.

Methodology

Homologous gene replacement was attempted in BCG vaccine strains, and sequence analyses were performed to identify mutations.

Limitations

The study focused only on specific BCG substrains and may not represent all variations.

Digital Object Identifier (DOI)

10.1186/1471-2180-8-120

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication